Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pasithea Therapeutics (KTTA) EBT Margin (2022 - 2023)

Historic EBT Margin for Pasithea Therapeutics (KTTA) over the last 2 years, with Q2 2023 value amounting to 1034.5%.

  • Pasithea Therapeutics' EBT Margin rose 150899300.0% to 1034.5% in Q2 2023 from the same period last year, while for Mar 2024 it was 4629.79%, marking a year-over-year decrease of 13146200.0%. This contributed to the annual value of 2410.37% for FY2022, which is 120201200.0% up from last year.
  • Pasithea Therapeutics' EBT Margin amounted to 1034.5% in Q2 2023, which was up 150899300.0% from 5475.32% recorded in Q1 2023.
  • In the past 5 years, Pasithea Therapeutics' EBT Margin registered a high of 5475.32% during Q1 2023, and its lowest value of 16124.43% during Q2 2022.